Company Data
IN8bio Inc.
Ticker
INAB
Current Price
$1.41 -1.4%
Market Cap
$13.9M
Price Target
Refer to Report
Volume
17.3K
52wk Range
$1.17 - $5.817
Overview
IN8bio Inc is a clinical-stage biotechnology company. It is focused on developing innovative therapies for the treatment of cancers, including solid tumors, by employing allogeneic, autologous and genetically modified gamma-delta T cells.